4
Changes in Ownership
Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-056316
Sinha Vikas sold 2,490 shares at $1.63 ($4,061)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-11-17 | Sale : show line 1 in the form 10b5-1 | −2,490 | $1.63 | $4,061 | 1,167,749 | D |
| Open-market sales · 2,490 sh · avg $1.63 · $4,061 | ||||||
Loading xslF345X05/doc4.xml…